Search Results

You searched for : monotherapy

	EASD 2024 \| HighTide Therapeutics Presents Oral Reports of Phase 2 Studies Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801).... Sep 11
	European Commission approves Teysuno in metastatic colorectal cancer Latest Corporate news updates; Pharma Feb 3rd 2022... Feb 03
	Innovent and GenFleet announce Exclusive Global License agreement for GFH925 (KRAS G12C Inhibitor) Latest Pharma News update... Sep 03
	ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors Latest Pharma News Update... Aug 31
	Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106 Latest Pharma Update... Aug 23
	Alkermes Receives FDA fast track designation for Nemvaleukin Alfa for the treatment of Mucosal Melanoma FDA News Update... Aug 05
	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ... Jul 12
	LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer Only PARP Inhibitor to Demonstrate Overall Survival Versus New Hormonal Treatments in BRCA1/2-Mutated Advanced Prostate Cancer... Jun 24
	Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas First medicine approved in the EU to treat this rare and debilitating genetic condition... Jun 22
	GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448 With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
	Bristol Myers Squibb announces LAG-3-Blocking antibody Relatlimab and Nivolumab fixed-dose Combination Significantly improves progression-free Survival vs. Opdivo (nivolumab) in patients... May 22
	GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19 GSK's Covid product could be soon in the market after the emergency medical application review... May 11
	Rocheâ€™s Tecentriq approved by European Commission for metastatic non-small cell lung cancer Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options... May 08
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19 The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
	Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA (lumateperone) CAPLYTA (lumateperone)is indicated for the treatment of Bipolar Depression... Feb 23
	Compugen expands clinical collaboration agreement with Bristol Myers Squibb Compugen Ltd expands collaboration agreement with Bristol Myers Squibb with phase 1b combination study of COM701 with opdivo C... Feb 22
	NMPA Approves Toripalimab in patients with recurrent or metastatic Nasopharyngeal Carcinoma Approval comes after Failure of at Least Two Lines of Prior Systemic Therapy... Feb 22
	BeiGene reports FDA approval for Brukinsa(Zanubrutinib ) Brukisa is indicated for the treatment of adult patients with WaldenstrÃ¶mâ€™s Macroglobulinemia ... Feb 19
	AtraZeneca's Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ... Jan 15
	FDA Grants Priority Review to Merckâ€™s Supplemental Biologics License Application for KEYTRUDA ... Dec 18
	Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.... Dec 14
	BAVENCIO receives positive CHMP opinion for first-line maintenance treatment of locally advanced or metastatic urothelial carcinoma This year US FDA has approved BAVENCIO for the maintenance treatment of patients with locally advanced or metastatic UC... Dec 12
	Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability ... Dec 11
25 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies

European Commission approves Teysuno in metastatic colorectal cancer

Innovent and GenFleet announce Exclusive Global License agreement for GFH925 (KRAS G12C Inhibitor)

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

Alkermes Receives FDA fast track designation for Nemvaleukin Alfa for the treatment of Mucosal Melanoma

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC

LYNPARZA (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

Koselugo approved in the EU for children with neurofibromatosis type 1 and plexiform neurofibromas

GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448

Bristol Myers Squibb announces LAG-3-Blocking antibody Relatlimab and Nivolumab fixed-dose Combination

GSK and Vir Biotechnology starts EMA rolling review of VIR-7831 (sotrovimab) for treatment of COVID-19

Rocheâ€™s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

GSK and Vir Biotechnology requests emergency use authorization to FDA for VIR-7831 for treatment of COVID-19

Intra-Cellular Therapies Applies for FDA Approval of CAPLYTA (lumateperone)

Compugen expands clinical collaboration agreement with Bristol Myers Squibb

NMPA Approves Toripalimab in patients with recurrent or metastatic Nasopharyngeal Carcinoma

BeiGene reports FDA approval for Brukinsa(Zanubrutinib )

AtraZeneca's Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer

FDA Grants Priority Review to Merckâ€™s Supplemental Biologics License Application for KEYTRUDA

Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer

BAVENCIO receives positive CHMP opinion for first-line maintenance treatment of locally advanced or metastatic urothelial carcinoma

Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability

Trending Now